191 related articles for article (PubMed ID: 35847083)
1. Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China.
Li G; Liu Z; Ren F; Shi H; Zhao Q; Song Y; Fan X; Ma X; Qin G
Front Microbiol; 2022; 13():911992. PubMed ID: 35847083
[TBL] [Abstract][Full Text] [Related]
2. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.
Zhou L; Ni Z; Yu J; Cheng W; Cai Z; Yu C
Front Endocrinol (Lausanne); 2020; 11():628. PubMed ID: 33013704
[No Abstract] [Full Text] [Related]
3. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
4. Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome.
Tayachew B; Vanden Brink H; Garcia-Reyes Y; Rahat H; D'Alessandro A; Frank DN; Robertson CE; Silveira L; Kelsey M; Pyle L; Cree-Green M
Front Physiol; 2022; 13():887077. PubMed ID: 35800349
[No Abstract] [Full Text] [Related]
5. Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study.
Yu Z; Qin E; Cheng S; Yang H; Liu R; Xu T; Liu Y; Yuan J; Yu S; Yang J; Liang F
Sci Rep; 2022 Dec; 12(1):22184. PubMed ID: 36564416
[TBL] [Abstract][Full Text] [Related]
6. Blood Bacterial 16S rRNA Gene Alterations in Women With Polycystic Ovary Syndrome.
Wang Q; Wang Q; Zhao L; Bin Y; Wang L; Wang L; Zhang K; Li Q
Front Endocrinol (Lausanne); 2022; 13():814520. PubMed ID: 35282443
[TBL] [Abstract][Full Text] [Related]
7. The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population.
He F; Li Y
J Ovarian Res; 2021 Mar; 14(1):50. PubMed ID: 33773586
[TBL] [Abstract][Full Text] [Related]
8. Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome.
Lin W; Wen L; Wen J; Xiang G
Front Endocrinol (Lausanne); 2021; 12():747888. PubMed ID: 34858330
[TBL] [Abstract][Full Text] [Related]
9. Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population.
Mammadova G; Ozkul C; Yilmaz Isikhan S; Acikgoz A; Yildiz BO
Eur J Clin Invest; 2021 Apr; 51(4):e13417. PubMed ID: 32991745
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome.
Yang Z; Fu H; Su H; Cai X; Wang Y; Hong Y; Hu J; Xie Z; Wang X
Front Microbiol; 2022; 13():1017147. PubMed ID: 36338055
[TBL] [Abstract][Full Text] [Related]
11. Changes in Vaginal Microbiome Diversity in Women With Polycystic Ovary Syndrome.
Lu C; Wang H; Yang J; Zhang X; Chen Y; Feng R; Qian Y
Front Cell Infect Microbiol; 2021; 11():755741. PubMed ID: 34804995
[TBL] [Abstract][Full Text] [Related]
12. Gut Metabolites Are More Predictive of Disease and Cohoused States than Gut Bacterial Features in a Polycystic Ovary Syndrome-Like Mouse Model.
Ho B; Ryback D; Benson B; Mason CN; Torres PJ; Quinn RA; Thackray VG; Kelley ST
mSystems; 2021 Oct; 6(5):e0114920. PubMed ID: 34519532
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Flora is a Key Factor in Insulin Resistance and Contributes to the Development of Polycystic Ovary Syndrome.
Yang YL; Zhou WW; Wu S; Tang WL; Wang ZW; Zhou ZY; Li ZW; Huang QF; He Y; Zhou HW
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34145455
[TBL] [Abstract][Full Text] [Related]
14. Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients.
Chen F; Chen Z; Chen M; Chen G; Huang Q; Yang X; Yin H; Chen L; Zhang W; Lin H; Ou M; Wang L; Chen Y; Lin C; Xu W; Yin G
NPJ Biofilms Microbiomes; 2021 Jul; 7(1):60. PubMed ID: 34267209
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.
Torres PJ; Siakowska M; Banaszewska B; Pawelczyk L; Duleba AJ; Kelley ST; Thackray VG
J Clin Endocrinol Metab; 2018 Apr; 103(4):1502-1511. PubMed ID: 29370410
[TBL] [Abstract][Full Text] [Related]
16. The gut microbial composition in polycystic ovary syndrome with hyperandrogenemia and its association with steroid hormones.
Li M; Chang Q; Luo Y; Pan J; Hu Y; Liu B; Ma M; Wang Q; Guo Y; Wang Q
Front Cell Dev Biol; 2024; 12():1384233. PubMed ID: 38872933
[No Abstract] [Full Text] [Related]
17. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Leber B; Horvath A; Pieber TR; Gorkiewicz G; Stadlbauer V; Obermayer-Pietsch B
PLoS One; 2017; 12(1):e0168390. PubMed ID: 28045919
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
19. 16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome.
Dong S; Jiao J; Jia S; Li G; Zhang W; Yang K; Wang Z; Liu C; Li D; Wang X
Front Cell Infect Microbiol; 2021; 11():634981. PubMed ID: 34041041
[TBL] [Abstract][Full Text] [Related]
20. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]